Treatment options for individuals with early-stage hidradenitis suppurativa (HS) vary depending on patient preference and how clinicians define “early” HS. This can be challenging because to date, no FDA-approved treatments exist for early-stage HS and only two biologics exist for moderate to severe disease. “For someone with occasional nodules and abscesses…
